Anteris Technologies Ltd (ASX:ARV) (OTCMKTS:AMEUF) (FRA:DDF) is a structural heart company delivering clinically superior and durable solutions through better science and better design.
Its focus is on developing next-generation technologies that help healthcare professionals create life-changing outcomes for patients.
The Anteris’ DurAVR™ aortic replacement valve addresses the acute need in terms of superior hemodynamic profile as well as chronic needs in its ability to sustain that profile longer over the lifetime of the patient.